MiniMax, a Chinese rival to OpenAI (OPENAI), unveiled its new M2.1 artificial intelligence model on Tuesday, stating it is “significantly enhanced” over previous offerings. Some of the highlights of ...

AI company MiniMax has announced the release of the multimodal model ' MiniMax M2.1.' It claims to be 'the most powerful open source model in the agent era,' and has even outperformed Gemini 3 Pro and ...

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Zhipu AI touted the high scores achieved by GLM-4.7 on various coding benchmarks that surpassed those of OpenAI’s GPT-5, which was released in August. GLM-4.7’s scores were just behind those of Google ...

MiniMax, a Chinese rival to OpenAI (OPENAI), unveiled its new M2.1 artificial intelligence model on Tuesday, stating it is “significantly enhanced” over previous offerings. “In M2.1, we are committed ...

MiniMax plans to price its Hong Kong initial public offering at the top of the marketed range, people familiar with the matter said, reflecting investor enthusiasm for Chinese startups that are ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Chinese AI startup MiniMax is considering an IPO in Hong Kong, Bloomberg News reported. MiniMax, one of China’s so-called 'new AI tigers or dragons which is valued at about $3B, could aim to list as ...

IT之家 12 月 24 日消息，MiniMax 昨日宣布为其 MiniMax M2 开源模型推出 M2.1 版本更新。此次更新致力于提升真实世界复杂任务中的表现：重点聚焦于更多编程语言和办公场景的可用性。 MiniMax-M2.1 的具体亮点如下： 系统性提升了 Rust / Java / Golang / C++ / Kotlin / Objective-C ...

前述内容由第一财经“星翼大模型”智能生成，相关AI内容力求但不保证准确性、时效性、完整性等。请用户注意甄别，第一财经不承担由此产生的任何责任。 如您有疑问或需要更多信息，可以联系我们 [email protected] MiniMax通过港交所聆讯 据新华网，12月21日 ...